Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Abenza is a pharmaceutical company based in Mexico that specializes in the development, manufacturing, and commercialization of high-quality generic medications. The company focuses on providing affordable therapeutic options across various medical fields, with a notable presence in oncology and specialized treatments. One of its key products is Abenza (abiraterone acetate), used in the treatment of metastatic castration-resistant prostate cancer. Abenza operates with a commitment to international quality standards, ensuring that essential medicines are accessible to the Mexican healthcare market. The company's portfolio includes a range of oral solids and other formulations designed to meet the needs of both public and private health sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Abenza.